DNP 825 Topic 8 sustainability and funding analysis example

Population Management Grand Canyon University Free custom sample in 24 to 48h

This DNP 825 Topic 8 sample paper funds hypertension telemonitoring past a grant ending June 30, 2029 by tracing who pays and who saves. It was prepared for GCU DNP 825, Population Management, catalog code DNP-825, completed by learners in the DNP at Grand Canyon University. The program costs about $262,000 a year, roughly $655 per patient, mostly pharmacist time. Its value comes from avoided cardiovascular events, with Margolis and colleagues' five-year cost findings. Insurers capture most savings, and 38 percent of eligible patients are in Medicare Advantage. Scheirer explains why programs stop with grants. Two arrangements align incentives, and a timeline runs back from March 1, 2029.

CourseDNP 825 Population Management
TopicTopic 8
Paper typeProgram sustainability financing
LengthAbout 1,060 words, 3 pages
FormatAPA 7 student paper
SchoolGrand Canyon University (GCU)
ProgramDNP
UpdatedOctober 2026

Free sample paper for DNP 825 Topic 8

1

The System Pays, the Plans Save: Funding Hypertension Telemonitoring Past the Grant That Ends June 30, 2029

[Author Name]

College of Nursing and Health Care Professions, Grand Canyon University

DNP-825: Population Management

Topic 8 Assignment

[Instructor Name]

September 20, 2027

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

What this page is doingThe title states the mismatch and the date, which are the two facts the sustainability plan is built around. The health system, grant and payer mix are composites; trial costs and outcomes are from the cited studies.
2

The System Pays, the Plans Save: Funding Hypertension Telemonitoring Past the Grant That Ends June 30, 2029

What the Program Costs Each Year

The telemonitoring and pharmacist titration program proposed in Topic 7 costs about $262,000 a year to run for 400 patients, or roughly $655 per patient. The largest component by far is staff: 1.5 full-time pharmacist positions at about $195,000, which is three-quarters of the total. Monitors and cellular hubs cost $38,000 in the first year and about $10,000 a year after that for replacements and new enrollees. The platform subscription costs $28,800. Medical assistant enrollment time, about 300 hours, is absorbed by the recheck visits the program replaces. The pilot's first two years are funded by a state health foundation grant of $540,000, which ends on June 30, 2029.

What the Program Is Worth, in the Same Units

The benefit of better blood pressure control is avoided cardiovascular events, and for this model there is direct evidence of their cost. Over five years of follow-up in the Minnesota trial, the intervention group had a cardiovascular composite event rate of 4.4 percent against 8.6 percent with usual care, a difference that did not reach statistical significance (odds ratio 0.49, p = 0.09). The intervention cost $1,511 per patient in 2017 dollars, and estimated event costs over five years were $758,000 in the intervention group and $1,538,000 with usual care, a net saving of about $1,900 per patient and a return on investment of 126 percent (Margolis et al., 2020). The event difference was not significant, so the savings estimate carries real uncertainty. Applied cautiously to 400 patients, a program costing less than half as much per patient as the trial version could still be expected to avoid several hundred thousand dollars in event costs over five years if even part of the trial's effect is reproduced.

Who Captures That Value

The avoided costs are hospital admissions for stroke, heart attack and heart failure, and in a fee-for-service arrangement those costs are paid by insurers. Among the 2,450 eligible patients, 38 percent are in Medicare Advantage plans, 27 percent in traditional Medicare, 21 percent in commercial plans and 14 percent in Medicaid managed care. For each of those payers, an avoided stroke admission is money not spent. For the health system, the same avoided admission is revenue not received at its own hospitals. The system bears the full cost of the pharmacists and devices and, under fee-for-service, loses some hospital income when the program works. Almost no one in the system's finance office is paid to notice that the program saves money, because the savings appear on someone else's books.

Why Programs Like This Stop When the Grant Does

This mismatch explains a familiar pattern. A grant pays for the program, the outcomes improve, and when the grant ends the delivery organization faces a recurring cost with no recurring revenue attached. A review of empirical studies of program sustainability found that programs were often sustained only in part after initial funding, and that sustainability was more likely when a program could be modified, had a champion, fit the organization's mission and was seen to benefit staff and clients (Scheirer, 2005). This program can meet all four. None of them replaces a recurring source of money, which is what it lacks. There is also a clinical reason not to let it lapse: in the Minnesota trial, the blood pressure advantage lasted about 24 months and had faded by 54 months, after the intervention had ended at 12 months (Margolis et al., 2018). A program that enrolls patients and then stops does not keep its effect.

Two Arrangements That Would Align the Incentive

The first is a shared-savings contract with the largest Medicare Advantage plan, which covers about 930 of the 2,450 eligible patients. Under such a contract, the plan would pay the system a monthly amount for each of its members enrolled in the program, or a share of the difference between expected and actual cardiovascular admission costs for enrolled members, measured against a matched comparison group. It would require the system to produce claims-matched outcome data the plan trusts, a baseline agreed before enrollment and a contract term of at least three years, since event savings take time to appear.

The second is to carry the risk. The system already participates in a Medicare accountable care organization for its traditional Medicare patients, currently in a track with shared savings but no downside risk. Moving to a track with downside risk would let the system keep a larger share of savings it generates, which makes avoided admissions a benefit rather than lost revenue. That decision is larger than this program and would be made on the whole accountable care organization's performance, but the program's data would be part of the case. In the meantime, the remote monitoring services themselves can be billed to traditional Medicare under the physiologic monitoring codes when the documentation requirements are met, which would cover part of the device and monitoring cost for the 27 percent of patients in traditional Medicare.

The Timeline Back From June 30, 2029

Working backward from the grant's end date: the system's fiscal year begins July 1, and budget requests for fiscal year 2030 are due March 1, 2029. The pharmacist positions must be in that request, funded by a combination of the Medicare Advantage contract, remote monitoring billing and operating funds, or they end with the grant. A Medicare Advantage contract of this kind takes nine to twelve months to negotiate, so the proposal must go to the plan by June 2028, which means the first six months of pilot data must be analyzed by May 2028; enrollment beginning in January 2028 makes that just possible. Remote monitoring billing must be set up and tested by October 2028, so that a full quarter of billed revenue is visible before the budget request. The accountable care organization's decision on its risk track for 2030 is made in the late summer of 2029, too late to rescue the program on its own, so it is treated as a longer-term route rather than the plan. The lead pharmacist and the population health director own the plan contract; the revenue cycle manager owns the billing setup; and I will present the pilot data at the population health committee in May 2028 so the timeline starts on schedule.

What this page is doingThe plan follows the money to the payer, explains why the mismatch ends grant-funded programs, and builds its timeline backward from the funding end date and the budget calendar.
3

References

Margolis, K. L., Asche, S. E., Dehmer, S. P., Bergdall, A. R., Green, B. B., Sperl-Hillen, J. M., Nyboer, R. A., Pawloski, P. A., Maciosek, M. V., Trower, N. K., & O'Connor, P. J. (2018). Long-term outcomes of the effects of home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertension: Follow-up of a cluster randomized clinical trial. JAMA Network Open, 1(5), Article e181617. https://doi.org/10.1001/jamanetworkopen.2018.1617

Margolis, K. L., Dehmer, S. P., Sperl-Hillen, J., O'Connor, P. J., Asche, S. E., Bergdall, A. R., Green, B. B., Nyboer, R. A., Pawloski, P. A., Trower, N. K., & Maciosek, M. V. (2020). Cardiovascular events and costs with home blood pressure telemonitoring and pharmacist management for uncontrolled hypertension. Hypertension, 76(4), 1097-1103. https://doi.org/10.1161/HYPERTENSIONAHA.120.15492

Scheirer, M. A. (2005). Is sustainability possible? A review and commentary on empirical studies of program sustainability. American Journal of Evaluation, 26(3), 320-347. https://doi.org/10.1177/1098214005278752

Reading the GCU DNP 825 Topic 8 instructions

Topic 8 in DNP-825 asks students to plan how a population program will be sustained. Strong papers state what the program costs each year and what it is worth in the same units, then trace who pays the costs and who captures the savings, since programs often stop when those parties differ. Students should explain why grant-funded programs commonly end with the grant, propose arrangements that would align the incentive, such as shared-savings contracts with payers, and build a timeline backward from the funding end date through the organization's budget calendar. The plan should name what must be decided at each step and by whom.

How this DNP 825 Topic 8 example is built

The finished example follows the money in both directions. The program costs a stated amount annually, mostly in staff time, and it produces savings by preventing admissions. The awkward finding is that the savings accrue to the payer while the costs fall on the delivery organization, which explains why programs of this kind get funded by grants and then stop. The paper works through what would change that: a contract arrangement that shares the savings, or a payment model in which the organization carries risk and therefore benefits. Grant dependence is treated as a real risk with a date attached, since the funding ends in a stated month. The sustainability plan is built around securing a recurring source before that month rather than after.

Where the marks sit in the DNP 825 Topic 8 rubric

Faculty reward costs and savings placed with whoever bears them. An Excellent paper costs the program at about $262,000 a year and values it in avoided events, using Margolis and colleagues' five-year cost analysis. Credit goes to showing that insurers capture the savings, with 38 percent of eligible patients in Medicare Advantage plans. The rubric values Scheirer on why programs end with grants. Strong papers propose a shared-savings contract with the plan covering about 930 patients. Top marks go to a timeline run back from budget requests due March 1, 2029.

Common DNP 825 Topic 8 mistakes, and how to avoid them

Sustainability sections asserting that a program will continue if it demonstrates value are the standard version and ignore who receives that value. A second failure is stating a total cost with no components, which prevents anyone from seeing that most of it is staff time and therefore recurring. Marks also go for omitting the funding end date, since the whole plan should be built backwards from it. Papers that treat savings as automatically returning to the delivering organization misread how most arrangements work. Benefits described without a monetary figure cannot be set against a cost. Plans with no alternative funding route depend entirely on a renewal nobody has promised. Costs presented as a single annual figure hide whether the money is recurring or one time.

Get a DNP-825 Topic 8 example written to your instructions

Send the DNP-825 Topic 8 instructions and the rubric your classroom posts, with the program your section assigned. We write a custom example to those criteria, tracing cost and benefit in the same units, identifying who captures the value and building a timeline back from the funding end date, in 24 to 48 hours. The first is free.

More DNP 825 papers and DNP samples

DNP 825 Topic 8 questions, answered

Why do successful programs still get cut?

Usually because the party that saves is not the party that spends. A care management program that prevents admissions reduces what a payer disburses while the delivering organization carries the staffing cost. Without an arrangement that shares the saving, the program is a net expense to the people paying for it however well it works. That mismatch explains more closures than performance does.

What actually makes a program sustainable?

A recurring funding source that survives a change of leadership, and an owner who is accountable for it in their ordinary role. Grants and pilot budgets are neither. Naming the specific line the program would sit on, and who would defend it in a budget review, is what a sustainability section is supposed to establish.

How should the timeline work?

Backwards from the funding end date. If the grant ends in a stated month, work back through when a decision has to be made, when the case must be submitted, and when the evidence supporting it must be complete. Programs that begin looking for continuation funding after the results are in have usually missed the budget cycle that could have supplied it.

Where can I find a free DNP 825 Topic 8 sample paper?

The sustainability paper for DNP 825 Topic 8 covers what the program costs, what it is worth, who captures the value, why programs stop when grants do, two aligning arrangements and the timeline back from June 30, 2029. Send your DNP 825 Topic 8 prompt and a paper follows free.

Why do successful programs get cut in DNP 825 Topic 8?

Usually because the organization paying for the program is not the one capturing its savings. Hospitals pay for pharmacists while insurers avoid the admission costs.